Skip to main content

Table 4 Multivariate analysis of prognostic factors

From: Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram

Prognostic factors HR 95% CI P value
Gender (male/female) 1.297 0.954–1.762 0.097
KPS (<80/≥80) 2.087 1.539–2.831 <0.001
Metachronous/Synchronous 0.685 0.489–0.961 0.028
ECM (N/Y) 0.749 0.054–1.012 0.060
Histology (non-adenocarcinoma/adenocarcinoma) 1.303 1.114–1.524 0.001
  1. MST median survival time, KPS Karnofsky performance status, ECM extracranial metastases